Ledger.Open graph →
SEC Form D · filed March 4, 2026

IMMUNIC, INC

Offering
$200.0M
Sold
$200.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, X1
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Hella Kohlhof · New York, NYExecPatrick Walsh · Bronson, FLExecJason Tardio · New York, NYExecDuane Nash · New York, NYDirectorTamar Howson · New York, NYDirectorSimona Skerjanec · NEW YORK, NYDirectorThorvald Nagel · New York, NYDirectorRichard Rudick · New York, NYDirectorInderpal Singh · New York, NYExecGlenn Whaley · New York, NYExecAndreas Muehler · New York, NYExecBarclay Phillips · New York, NYDirectorJoerg Neerman · New York, NYDirectorDaniel Vitt · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗